48
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Fabrication, optimisation and evaluation of cisplatin-loaded nanostructured carriers for improved urothelium permeability for intravesical administration

, , &
Pages 405-413 | Received 03 Feb 2021, Accepted 14 Jul 2021, Published online: 26 Jul 2021

References

  • Alany, R.G., et al., 2000. Effects of alcohols and diols on the phase behaviour of quaternary systems. International journal of pharmaceutics, 196 (2), 141–145.
  • Ali, F.R., et al., 2017. Design, development, and optimization of dexibuprofen microemulsion based transdermal reservoir patches for controlled drug delivery. BioMed research international, 2017, 4654958.
  • Avan, A., et al., 2015. Platinum-induced neurotoxicity and preventive strategies: past, present, and future. The oncologist, 20 (4), 411–432.
  • Azeem, A., et al., 2009. Nanocarrier for the transdermal delivery of an antiparkinsonian drug. AAPS PharmSciTech, 10 (4), 1093–1103.
  • Baboota, S., et al., 2007. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta pharmaceutica, 57 (3), 315–332.
  • Becker, L.C., et al., 2012. Safety assessment of trimoniums as used in cosmetics. International journal of toxicology, 31 (6 Suppl), 296S–341S.
  • Boonme, P., et al., 2016. Microemulsion and microemulsion-based gels for topical antifungal therapy with phytochemicals. Current pharmaceutical design, 22 (27), 4257–4263.
  • Callender, S.P., et al., 2017. Microemulsion utility in pharmaceuticals: implications for multi-drug delivery. International journal of pharmaceutics, 526 (1–2), 425–442.
  • Chen, Y.C., et al., 2015. Optimization and validation of high-performance chromatographic condition for simultaneous determination of adapalene and benzoyl peroxide by response surface methodology. PLOS one, 10 (3), e0120171.
  • Clark, P.E., 2007. Bladder cancer. Current opinion in oncology, 19 (3), 241–247.
  • Duangjit, S., et al., 2016. Development, characterization and skin interaction of capsaicin-loaded microemulsion-based nonionic surfactant. Biological & pharmaceutical bulletin, 39 (4), 601–610.
  • Erdal, M.S., et al., 2016. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations. International journal of nanomedicine, 11, 1027–1037.
  • Ghosh, S., 2019. Cisplatin: the first metal based anticancer drug. Bioorganic chemistry, 88, 102925.
  • Gupta, S., 2011. Biocompatible microemulsion systems for drug encapsulation and delivery. Current science, 101, 174–188.
  • Gupta, S., et al., 2020. Isotretinoin and α-tocopherol acetate-loaded solid lipid nanoparticle topical gel for the treatment of acne. Journal of microencapsulation, 37 (8), 557–565.
  • Hwang, T.L., et al., 2009. Permeation enhancer-containing water-in-oil nanoemulsions as carriers for intravesical cisplatin delivery. Pharmaceutical research, 26 (10), 2314–2323.
  • Ita, K., 2016. Progress in the use of microemulsions for transdermal and dermal drug delivery. Pharmaceutical development and technology, 22, 1–9.
  • Kamairudin, N., et al., 2014. Optimization of natural lipstick formulation based on pitaya (Hylocereus polyrhizus) seed oil using D-optimal mixture experimental design. Molecules, 19 (10), 16672–16683.
  • Kirkali, Z., et al., 2005. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology, 66 (6), 4–34.
  • Koenig, F., et al., 1999. Near-infrared confocal laser scanning microscopy of bladder tissue in vivo. Urology, 53 (4), 853–857.
  • Kohli, A.K., et al., 2004. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. International journal of pharmaceutics, 275 (1–2), 13–17.
  • Lanke, S.S., et al., 2009. Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation. International journal of pharmaceutics, 365 (1–2), 26–33.
  • Liu, P., et al., 2011. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. International journal of pharmaceutics, 411 (1–2), 215–222.
  • Lopes, L.B., 2014. Overcoming the cutaneous barrier with microemulsions. Pharmaceutics, 6 (1), 52–77.
  • Lopez-Flores, A., et al., 2005. A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples. Journal of pharmacological and toxicological methods , 52 (3), 366–372.
  • Mahrhauser, D.S., et al., 2015. Investigation of microemulsion microstructure and its impact on skin delivery of flufenamic acid. International journal of pharmaceutics, 490 (1–2), 292–297.
  • Milosavljevic, N., et al., 2010. Nongenomic effects of cisplatin: acute inhibition of mechanosensitive transporters and channels without actin remodeling. Cancer research, 70 (19), 7514–7522.
  • Mostafa, D.M., et al., 2015. Transdermal microemulsions of Boswellia carterii Bird: formulation, characterization and in vivo evaluation of anti-inflammatory activity. Drug delivery, 22 (6), 748–756.
  • Naeem, M., et al., 2015. Physicochemical, in vitro and in vivo evaluation of flurbiprofen microemulsion. Anais da academia brasileira de ciencias, 87 (3), 1823–1831.
  • Nasr, M., et al., 2016. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modeling. Drug development and industrial pharmacy, 42 (4), 636–643.
  • Negin, C., et al., 2017. Most common surfactants employed in chemical enhanced oilrecovery. Petroleum, 3 (2), 197–211.
  • Osborne, D.W., et al., 2018. Skin penetration and permeation properties of transcutol(R)-neat or diluted mixtures. AAPS PharmSciTech, 19 (8), 3512–3533.
  • Panda, J., et al., 2021. Anticancer potential of docetaxel-loaded cobalt ferrite nanocarrier: an in vitro study on MCF-7 and MDA-MB-231 cell lines. Journal of microencapsulation, 38 (1), 36–46.
  • Patel, P., et al., 2014. Colloidal soft nanocarrier for transdermal delivery of dopamine agonist: ex vivo and in vivo evaluation. Journal of biomedical nanotechnology, 10 (11), 3291–3303.
  • Pecoraro, M., et al., 2020. Overview of VI-RADS in bladder cancer. AJR. American journal of roentgenology, 214 (6), 1259–1268.
  • Program, A.P.R., 2016. 2016 Fellows of the American Society of Health-System Pharmacists. American journal of health system pharmacy, 73, 1010.
  • Qidwai, A., et al., 2016. Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma. Drug delivery, 23 (4), 1476–1485.
  • Rocha, C.R.R., et al., 2018. DNA repair pathways and cisplatin resistance: an intimate relationship. Clinics, 73 (Suppl 1), e478s.
  • Said, M., et al., 2017. Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability. Drug delivery, 24 (1), 1159–1169.
  • Shakeel, F., et al., 2013. Impact of various nonionic surfactants on self-nanoemulsification efficiency of two grades of Capryol (Capryol-90 and Capryol-PGMC). Journal of molecular liquids, 182, 57–63.
  • Todosijevic, M.N., et al., 2015. Biocompatible microemulsions of a model NSAID for skin delivery: a decisive role of surfactants in skin penetration/irritation profiles and pharmacokinetic performance. International journal of pharmaceutics, 496, 931–941.
  • Tsai, M.J., et al., 2016. Nanocarriers enhance the transdermal bioavailability of resveratrol: in-vitro and in-vivo study. Colloids and surfaces B: biointerfaces, 148, 650–656.
  • Tsai, Y.H., et al., 2010. Microemulsions for intravesical delivery of gemcitabine. Chemical & pharmaceutical bulletin, 58 (11), 1461–1465.
  • Vojinovic, T., et al., 2018. Development of ternary solid dispersions with hydrophilic polymer and surface adsorbent for improving dissolution rate of carbamazepine. Saudi pharmaceutical journal, 26, 725–732.
  • Wang, H., et al., 2014. Optimization of madecassoside liposomes using response surface methodology and evaluation of its stability. International journal of pharmaceutics, 473 (1–2), 280–285.
  • Zou, Y., et al., 2017. Confocal laser scanning microscopy to estimate nanoparticles' human skin penetration in vitro. International journal of nanomedicine, 12, 8035–8041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.